APT Medical Inc (688617) — Cash Flow Reinvestment Rate
APT Medical Inc (688617) has a Cash Flow Reinvestment Rate of 0.67x as of December 2025, reinvesting CN¥196.93 Million (capex CN¥52.10 Million plus investments CN¥144.83 Million) from operating cash flow of CN¥294.68 Million. Explore capital reinvestment ratio of APT Medical Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
APT Medical Inc Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for APT Medical Inc across 9 annual periods. Also explore balance sheet size of APT Medical Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for APT Medical Inc (2017–2025)
Year-by-year capital reinvestment analysis for APT Medical Inc. For live market cap and broader valuation context, see 688617 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | CN¥501.12 Million | CN¥975.30 Million | CN¥285.59 Million | ▼ -43.9% |
| 2024 | 0.92x | CN¥681.04 Million | CN¥743.39 Million | CN¥650.24 Million | ▼ -19.5% |
| 2023 | 1.14x | CN¥783.93 Million | CN¥689.06 Million | CN¥202.03 Million | ▲ +50.5% |
| 2022 | 0.76x | CN¥277.73 Million | CN¥367.46 Million | CN¥143.21 Million | ▼ -89.3% |
| 2021 | 7.04x | CN¥1.28 Billion | CN¥181.39 Million | CN¥167.38 Million | ▲ +2223.6% |
| 2020 | 0.30x | CN¥44.93 Million | CN¥148.24 Million | CN¥44.20 Million | ▼ -87.7% |
| 2019 | 2.47x | CN¥135.59 Million | CN¥54.90 Million | CN¥67.56 Million | ▲ +42.9% |
| 2018 | 1.73x | CN¥32.20 Million | CN¥18.63 Million | CN¥32.20 Million | ▼ -11.7% |
| 2017 | 1.96x | CN¥25.26 Million | CN¥12.91 Million | CN¥25.26 Million | — |